BRAINSCOPE COMPANY INC

Company profile

About BRAINSCOPE COMPANY INC

BrainScope is a leading neurotechnology company with over 15 years of experience advancing brain health through objective, AI-powered insights derived from brain electrical activity (EEG). The company has developed a first-in-class, AI-driven platform that combines computational neuroscience with state-of-the-art machine and deep learning to greatly expand the clinical utility of traditional EEG. BrainScope's proprietary platform analyzes EEG data from any source to deliver rapid, radiation-free, accessible, and cost-effective biomarkers. The company holds the distinction of developing the first FDA-cleared AI/machine learning medical device in the field of neurology. BrainScope's initial commercial product remains the only point-of-care technology that objectively assesses head-injured patients for both brain bleeds and concussions. The company has commercialized three FDA-cleared biomarkers for mild brain injury assessment, achieving remarkable outcomes in major U.S. health systems including approximately 50% reduction in unnecessary head CTs and substantial reductions in patient length of stay in emergency departments. Building on this foundation, BrainScope is advancing novel biomarkers for early Alzheimer's detection, ARIA assessment, rapid stroke evaluation, concussion subtyping, military blast exposure, and brain fog. The company's Large Neural Model platform brings breakthroughs similar to Large Language Models to bear on EEG data, eliminating the need for specialized qEEG interpretation. BrainScope is redefining how brain health is managed across acute care, drug development, and consumer health applications.

Company description · BRAINSCOPE COMPANY INC official website